NEU neuren pharmaceuticals limited

Ann: Investor Presentation, 8 January 2015, page-41

  1. 2,504 Posts.
    lightbulb Created with Sketch. 55
    Good questions.
    For the first one, we can only assume the NEU want to point out at this stage where the positive effects are.

    For the second, I don't it your way. I read it that improvements occured only while taking the medication, and that regression to the mean occurs only after ceasing the medication (ie the experimental arms effect decays once you stop and it regresses back to that of the control once medication ceases).

    There is no problem with subjective responses from caregivers as remember, subjects themselves would be too disabled to respond. It is important that caregivers themselves note changes.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.02
Change
0.170(1.32%)
Mkt cap ! $1.626B
Open High Low Value Volume
$13.15 $13.37 $12.92 $5.764M 439.6K

Buyers (Bids)

No. Vol. Price($)
18 660 $13.01
 

Sellers (Offers)

Price($) Vol. No.
$13.03 483 11
View Market Depth
Last trade - 15.06pm 18/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.